首页> 美国卫生研究院文献>Journal of Korean Medical Science >Long-term Experience with the Björk-Shiley Monostrut Tilting Disc Valve
【2h】

Long-term Experience with the Björk-Shiley Monostrut Tilting Disc Valve

机译:Björk-ShileyMonostrut倾斜式碟形阀的长期经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Björk-Shiley Monostrut valve is tilting disc mechanical valve prosthesis. This study was designed to present the long-term outcome of our experience. One hundred and thirty-seven Björk-Shiley Monostrut valves were implanted in 101 consecutive patients from November 1983 to February 1990. There were 60 male and 41 female with mean age of 34.5 yr at the time of operation. Fifty-nine patients underwent single valve replacement, 38 had double valve, and 4 had triple valve replacement. There were six in-hospital deaths (5.9%): three from cardiopulmonary bypass weaning failure and one each from septic shock, sudden cardiac arrest, and uncontrollable bleeding. Mean duration of follow-up was 181.2±76.2 months. Overall survival was 86.2% at 15 yr and 83.1% at 20 yr. Patients with mitral valve replacement had 93.5% and 90.2% cumulative survival at 10 and 15 yr, respectively, while patients with aortic valve replacement had 91.1% and 86.5% cumulative survival at 10 and 15 yr. Two groups had no significant difference in survival. Double valve replacement patients had 92.2% and 84.0% survival at 10 and 15 yr, respectively. There were no significant differences in survival between the single and double valve replacement groups. Freedom from thromboembolism was noted in: 97.8%, 97.8%, 96.4% and 87.8% at 5, 10, 15 and 20 yr, respectively. Absence of endocarditis was noted in 98.6% and 94.8% at 15 and 20 yr. Absence of reoperation was 92.5% at 20 yr. In conclusion, the Björk-Shiley Monostrut valve is reliable, with a similar incidence of valve-related morbidity as in other mechanical valves.
机译:Björk-ShileyMonostrut瓣膜是倾斜的椎间盘机械瓣膜假体。本研究旨在介绍我们经验的长期结果。 1983年11月至1990年2月,在101例连续患者中植入了137例Björk-ShileyMonostrut瓣膜。手术时平均年龄为34.5岁,男60例,女41例。 59例患者进行了单瓣置换,38例进行了双瓣置换,4例进行了三瓣置换。共有6例院内死亡(5.9%):3例因体外循环断奶失败而导致,3例因败血性休克,心脏骤停和无法控制的出血而死亡。平均随访时间为181.2±76.2个月。 15年和20年时总生存率为86.2%和83.1%。二尖瓣置换术患者在10和15年时的累积生存率分别为93.5%和90.2%,而主动脉瓣置换术患者在10和15年时的累积生存率分别为91.1%和86.5%。两组生存率无明显差异。双瓣置换患者在10年和15年时的存活率分别为92.2%和84.0%。单瓣和双瓣置换组的生存率无显着差异。分别在5、10、15和20年分别有97.8%,97.8%,96.4%和87.8%的患者免受血栓栓塞的困扰。在15和20年时,心内膜炎的发生率分别为98.6%和94.8%。 20年时无再次手术的发生率为92.5%。总之,Björk-ShileyMonostrut阀是可靠的,与阀相关的发病率与其他机械阀类似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号